Originally launched in Pennsylvania, Oshi Health is expanding to provide multidisciplinary gastrointestinal (GI) care in Florida in partnership with a leading health plan. The company is working with forward-thinking employers and health insurance plans to make its virtual medical and behavioral health clinic for GI conditions available to their populations and will launch in additional states throughout 2021. Oshi Health is the first virtual care clinic for gastrointestinal conditions designed around patient needs: convenience, accessibility, and centrally-coordinated care. Ending the siloed and fragmented experience of traditional GI care, an Oshi Health integrated care team includes a gastroenterologist, nurse practitioner, registered…
Author: Praveen Suthrum
EXTON, Pa., Feb. 17, 2021 /PRNewswire/ — US Digestive Health, a management services organization created to expand access to high-quality, low-cost gastroenterology care, announced today that it has closed partnerships with four Pennsylvania gastroenterology practices: Pottstown Ambulatory Center in Pottstown, Brandywine Valley Endoscopy in Downingtown, The Center for GI Health in Sellersville, and Hillmont Gastroenterology in Flourtown. Including these new partnerships, US Digestive Health now oversees a network of gastroenterology providers and services with 26 locations, 13 ambulatory surgery centers, 92 physicians, 36 advanced practice providers, and more than 700 total employees.
North Bergen, N.J.-based Hudson Bergen Endo Surgical Center was acquired by Physicians Endoscopy and North Bergen-based Ambulatory Center for Endoscopy in partnership with Teaneck, N.J.-based Holy Name Medical Center. Physicians Endoscopy’s strategic partnership with the Ambulatory Center for Endoscopy dates back to 2012, according to a Feb. 12 news release. Hudson Bergen Endo Surgical Center will be a second location for Ambulatory Center for Endoscopy. The center received accreditation from the Accreditation Association for Ambulatory Health Care in 2020. Partnering physicians Peter Caride, MD, Juan Gonzalez, MD, and John Sotiriadis, MD, PhD, are expected to perform more than 4,000 procedures annually.
President-elect Joe Biden unveiled a $1.9 trillion relief package that includes more than $400 billion to fight the COVID-19 pandemic directly. Here is a breakdown of 10 things to know about the proposal. A relatively high rate of COVID-19 vaccination intent was observed among inflammatory bowel disease populations; however, long-term safety concerns were common.
As we transition into the new year, and despite the arrival of effective vaccines for COVID-19, there’s little probability that telehealth physician services will decrease substantially anytime soon. Fortunately, the Centers for Medicare & Medicaid Services (CMS) and most private payors recognize the need to continue providing coverage for these remote services. The liberal stance that the agency took last spring will persist throughout the calendar year 2021, and at least until the end of the public health emergency for private payors.
Audax Private Equity could sell Miami-based Gastro Health in 2021 after nearly five years of ownership, according to a PE Hub report. Becker’s ASC Review spoke with Eric Major, director at Provident, and Praveen Suthrum, president of NextServices, a healthcare management company, about what a potential deal could look like, who the platform could sell to and what the ramifications of such a deal would mean to the industry. Note: Responses were presented alphabetically and edited for style and content. Question: What could a potential deal look like if Audax does sell Gastro Health this year? Eric Major: As an early mover in the consolidation of the…
Praveen Suthrum, President of NextServices interviews Dr. Ellen Scherl, Founding Director of the Jill Roberts Center for Inflammatory Bowel Disease. **** Scope Forward: The Future of Gastroenterology Is Now in Your Hands is now live on Amazon! Get your copies now – https://geni.us/scopeforward **** Dr. Ellen Scherl is the Research Director and Founding Director of the Jill Roberts Center for Inflammatory Bowel Disease (IBD), Weill Cornell Medicine. Dr. Scherl has recently been honored with the Rosenthal Humanitarian Award from the Crohn’s and Colitis Foundation. Dr. Scherl is known nationally and internationally for her work in the field of IBD.
It could take almost 9 more months to vaccinate 70% of Americans against SARS-CoV-2 infection and reach a herd immunity threshold, assuming the current pace of immunizations continues and requires a two-dose regimen with either the Pfizer/BioNTech or Moderna vaccines, a Medscape analysis reveals. Clinicians have administered a total 44,769,970 doses of COVID-19 vaccine in the United States as of February 11 according to the Centers for Disease Control and Prevention (CDC) COVID Data Tracker. Although the site also reports total US cases of COVID-19, total doses of vaccines delivered, and the number of Americans who have died, the agency doesn’t…
Non-Hispanic Black and Hispanic children were less likely to undergo radiography, CT, ultrasonography and an MRI during ED visits than non-Hispanic white children, an analysis of more than 13 million ED visits showed. “An important determinant of health care quality is the appropriate use of diagnostic testing for evaluating acute illness in children,” Jennifer R. Marin, MD, MSc, an associate professor of pediatrics and emergency medicine and medical director of point-of-care ultrasound at University of Pittsburgh Medical Center Children’s Hospital of Pittsburgh, and colleagues wrote.
When IBD patients self-report their adverse reactions to biological therapies, they could provide insights that shape and optimize treatments. That’s the goal of a recently created pharmacovigilance system to survey how patients think about and reacted to drug therapies. Understanding the patient experience could ultimately help bolster treatments, according to Pepjin Thomas, a doctoral candidate in the Department of Gastroenterology at Radboud University Medical Center, in Nijmegen, the Netherlands. “I think it will mainly add finding out what patients consider as adverse drug reactions and if that’s clear, you can improve medication adherence.”